Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.090
-0.030 (-2.68%)
Nov 21, 2024, 1:19 PM EST - Market open

Heron Therapeutics Statistics

Total Valuation

HRTX has a market cap or net worth of $165.78 million. The enterprise value is $277.70 million.

Market Cap 165.78M
Enterprise Value 277.70M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

HRTX has 152.09 million shares outstanding. The number of shares has increased by 16.83% in one year.

Current Share Class 152.09M
Shares Outstanding 152.09M
Shares Change (YoY) +16.83%
Shares Change (QoQ) +0.34%
Owned by Insiders (%) 1.01%
Owned by Institutions (%) 57.56%
Float 115.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.24
Forward PS 4.03
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.02
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.28

Current Ratio 2.28
Quick Ratio 1.61
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.75

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -2.31%
Return on Capital (ROIC) -3.58%
Revenue Per Employee $1.09M
Profits Per Employee -$221,960
Employee Count 126
Asset Turnover 0.61
Inventory Turnover 1.65

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.75% in the last 52 weeks. The beta is 1.81, so HRTX's price volatility has been higher than the market average.

Beta (5Y) 1.81
52-Week Price Change +2.75%
50-Day Moving Average 1.78
200-Day Moving Average 2.54
Relative Strength Index (RSI) 24.62
Average Volume (20 Days) 2,056,206

Short Selling Information

The latest short interest is 28.81 million, so 18.94% of the outstanding shares have been sold short.

Short Interest 28.81M
Short Previous Month 30.64M
Short % of Shares Out 18.94%
Short % of Float 25.05%
Short Ratio (days to cover) 20.19

Income Statement

In the last 12 months, HRTX had revenue of $137.74 million and -$27.97 million in losses. Loss per share was -$0.18.

Revenue 137.74M
Gross Profit 65.36M
Operating Income -8.32M
Pretax Income -48.13M
Net Income -27.97M
EBITDA -5.70M
EBIT -8.32M
Loss Per Share -$0.18
Full Income Statement

Balance Sheet

The company has $70.89 million in cash and $178.25 million in debt, giving a net cash position of -$107.36 million or -$0.71 per share.

Cash & Cash Equivalents 70.89M
Total Debt 178.25M
Net Cash -107.36M
Net Cash Per Share -$0.71
Equity (Book Value) -40.01M
Book Value Per Share -0.26
Working Capital 109.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.29 million and capital expenditures -$1.32 million, giving a free cash flow of -$9.61 million.

Operating Cash Flow -8.29M
Capital Expenditures -1.32M
Free Cash Flow -9.61M
FCF Per Share -$0.06
Full Cash Flow Statement

Margins

Gross margin is 47.45%, with operating and profit margins of -6.04% and -20.30%.

Gross Margin 47.45%
Operating Margin -6.04%
Pretax Margin -20.30%
Profit Margin -20.30%
EBITDA Margin -4.13%
EBIT Margin -6.04%
FCF Margin -16.51%

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.83%
Shareholder Yield -16.83%
Earnings Yield -16.42%
FCF Yield -5.64%

Analyst Forecast

The average price target for HRTX is $5.67, which is 420.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.67
Price Target Difference 420.18%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 18.78%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 13, 2014. It was a reverse split with a ratio of 0.05:1.

Last Split Date Jan 13, 2014
Split Type Reverse
Split Ratio 0.05:1

Scores

HRTX has an Altman Z-Score of -10.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -10.32
Piotroski F-Score 3